Man Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-74,601
Closed -$136K 2004
2022
Q4
$200K Buy
74,601
+64,301
+624% +$169K ﹤0.01% 1770
2022
Q3
$29K Buy
+10,300
New +$43.8K ﹤0.01% 1920
2021
Q4
Sell
-83,384
Closed -$1.63M 2178
2021
Q3
$1.63M Buy
83,384
+4,723
+6% +$180K 0.01% 1223
2021
Q2
$3.52M Buy
78,661
+5,137
+7% +$238K 0.01% 1031
2021
Q1
$3.69M Buy
73,524
+39,170
+114% +$2.67M 0.02% 838
2020
Q4
$3.07M Buy
34,354
+10,314
+43% +$868K 0.01% 1030
2020
Q3
$1.84M Buy
+24,040
New +$1.53M 0.01% 1217

Other funds holding CELL

Man Group's CELL Position: Q1 2023 in Review

Man Group sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 74,601 shares — an estimated $136K sold.

Man Group first reported a position in CELL in Q3 2020 and held it in 7 quarters. The position peaked at $3.69M in Q1 2021. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

  • Man Group reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Man Group sold 74,601 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $136K.
  • Man Group first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 7 quarters.
  • Man Group's PhenomeX Inc. Common Stock position peaked at $3.69M in Q1 2021.
  • 102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.